Global Leader in Specialty Therapeutics Selects Kneat to Digitize Validation

LIMERICK, Ireland, Jan. 09, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a leading global therapeutics company (“the Company”) has signed a three-year Master Services Agreement with Kneat to digitize its validation processes.

Read more at globenewswire.com